Learn More
Gibco™ CTS™ AIM V™ SFM
Description
Gibco Cell Therapy Systems (CTS) AIM-V SFM is a defined, serum-free medium specifically designed for the proliferation and/or manipulation of T cells, dendritic cells, and other immune cells that is manufactured in compliance with current Good Manufacturing Practice (cGMP) standards.
CTS AIM V SFM contains L-glutamine, 50 μg/mL streptomycin sulfate, and 10 μg/mL gentamicin sulfate.
CTS quality
Gibco CTS products are manufactured at a site that uses methods and controls that conform to cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485-certified. Gibco CTS products follow USP 'ancillary materials for cell, gene, and tissue-engineered products' within the responsibilities applicable to a supplier.*
Accompanied by documentation to support your regulatory filing
Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available.
*Other aspects of USP will be the responsibility of the end-user to assess. Thermo Fisher Scientific cannot fulfill USP in regards to application and therapy-specific aspects (e.g., residual assessment and removal of the Ancillary Material).
Specifications
Specifications
| Cell Type | Monocytes, Dendritic Cells, T Cells, Hybridomas, PBMCs, Fibroblasts, Macrophages, Myeloma Cells, Lymphocytes |
| Classification | Animal Origin |
| Form | Liquid |
| Product Type | Cell Culture Medium |
| Serum Level | Serum-free |
| Sterility | Sterile-filtered |
| For Use With (Application) | Cell and Gene Therapy Research, Development, and Manufacturing |
| Manufacturing Quality | ISO 13485, MDSAP, FDA-registered, 21 CFR 820 |
| Quantity | 10 L |
| Shipping Condition | Ambient |
| Show More |
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.
Your input is important to us. Please complete this form to provide feedback related to the content on this product.